UK Politicians Call for Full Competition Review of Netflix’s Warner Bros Discovery Deal 
Hermès Menswear Marks Historic Transition as Véronique Nichanian Bids Farewell in Paris 
Hyundai Motor Shares Slide After Trump Signals Higher U.S. Tariffs on South Korean Goods 
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin 
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
LVMH Succession Uncertainty Raises Governance Concerns Among Shareholders 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
ANTA Sports to Acquire Major Stake in Puma in €1.5 Billion Deal, Signaling Strategic Revival 
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Noble Corporation Secures $1.3 Billion in New Contracts, Strengthening Offshore Drilling Backlog 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
Baker Hughes Reports 11% Rise in Q4 Adjusted Profit Driven by LNG Demand 
Zijin Mining Shares Hit Record High on $4 Billion Allied Gold Acquisition 
Embraer Targets Growth as Regional Jet Demand Surges Post-Pandemic 
BETHLEHEM, Pa., May 16, 2017 -- B. Braun Medical Inc., an industry pioneer in offering products not made with PVC and DEHP, will showcase its portfolio of solution containers at the CleanMed 2017 Conference & Exposition on May 16-18 at the Minneapolis Convention Center.
“We’re focused on supplying a marketplace with an increasing demand for safe products,” said Rick Williamson, Vice President of Pharmaceutical and Drug Delivery Marketing at B. Braun. “We’re here for the long haul and making the investments to ensure that the healthcare industry is well served with quality medical supplies so clinicians can provide healing environments for their patients.”
In the past five years, B. Braun has spent more than $500 million in developing innovative ways to offer products not made with PVC and DEHP. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices to raise awareness and encourage change.
More than four decades ago, B. Braun recognized the environmental and patient risks posed by products containing PVC and DEHP. As a result, B. Braun was the first IV fluids manufacturer to remove these toxic substances from many products, and remains the only supplier that offers a full-line of IV solution containers that are not made with PVC or DEHP.
“B. Braun is committed to finding alternative methods to manufacture safer products, such as our TITAN™ XL irrigation bags and E3® IV containers,” Williamson said.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]
